Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

U.S. government plans to stop paying for COVID-19 vaccines 

By Brian Buntz | August 18, 2022

Pfizer-BioNTech vaccine

[Pfizer-BioNTech vaccine image courtesy of Wikimedia Commons.]

The Biden administration is in the process of transferring responsibility for COVID-19 vaccines to the healthcare industry, according to media reports.  

To date, the federal government has footed the bill for the shots, but the Trump and Biden administrations have intended to eventually cease that practice as the pandemic shifts to an endemic phase. 

Confirmed COVID-19 cases are declining steadily, reaching levels not seen since mid-May. 

HHS has scheduled a planning session dedicated to COVID-19 drug payments. The agency will invite representatives from pharma companies, pharmacies and state health departments to the meeting. The meeting will cover regulatory matters and treatment for uninsured patients. 

The transition to shifting financial liability for COVID-19 therapies to the private sector could take months, according to a WSJ article quoting an HHS spokesperson. 

The move could also be good news for the pharmaceutical industry, which likely will charge the private sector more for COVID-19 vaccines and drugs than it did the U.S. government.

White House Covid-19 Response Coordinator Dr. Ashish Jha recently told CNN that the U.S. government planned to continue investing in developing novel COVID-19 vaccines. Jha added, however, that the government would shift more of the pandemic response to the private sector. 

The U.S. government also bankrolled the COVID-19 vaccine initiative Operation Warp Speed, a multi-billion dollar public-private partnership. 

Earlier this year, the White House asked Congress for $10 billion in funding for the continued fight against COVID-19, but that initiative stalled. 

The federal government is currently working on obtaining updated COVID-19 vaccine boosters for distribution beginning in September or October. 


Filed Under: Infectious Disease
Tagged With: COVID-19 vaccines
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

covid-19 vaccine
FDA COVID booster pullback jolts vaccine stocks before gains cool
Coronavirus Covid-19 background - 3d rendering
Pregnancy associated with less long COVID: Researchers call for studies on protective biology
How technology advances are helping scientists unlock the mysteries of zoonotic diseases
Novel coronovirus
Advances in next generation vaccine development for SARS-CoV-2
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE